NSRS Stock Overview
Focuses on the manufacture and assembly of medicines, cosmetics, and health treatment products and drinks. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Medcann Industries, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.0001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -93.75% |
5 Year Change | -98.18% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
NSRS | US Metals and Mining | US Market | |
---|---|---|---|
7D | 0% | -3.0% | -2.2% |
1Y | n/a | 10.3% | 18.3% |
Return vs Industry: Insufficient data to determine how NSRS performed against the US Metals and Mining industry.
Return vs Market: Insufficient data to determine how NSRS performed against the US Market.
Price Volatility
NSRS volatility | |
---|---|
NSRS Average Weekly Movement | n/a |
Metals and Mining Industry Average Movement | 8.0% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 17.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NSRS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine NSRS's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | n/a | John Vivian | medcannindustries.com |
Medcann Industries, Inc. focuses on the manufacture and assembly of medicines, cosmetics, and health treatment products and drinks. The company was formerly known as North Springs Resources Corp. and changed its name to Medcann Industries, Inc. in January 2023. Medcann Industries, Inc. was founded in 2009 and is based in Riverview, Florida.
Medcann Industries, Inc. Fundamentals Summary
NSRS fundamental statistics | |
---|---|
Market cap | US$15.90k |
Earnings (TTM) | -US$7.80k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs NSRS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NSRS income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$7.80k |
Earnings | -US$7.80k |
Last Reported Earnings
Apr 30, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did NSRS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/23 12:05 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2021/04/30 |
Annual Earnings | 2021/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medcann Industries, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.